Cancer, Hold the Chemo

Admittedly there are some things that I would never conceive could possibly “run out” or “dry up,” even in the worst economic times. As a non-doctor, drugs are one of those things.

But imagine, if you will for a moment, having to call your friends to see if they could get you the much needed drug that your hospital could not supply. If you do not get the drug, you will not be able to keep your disease under control…

This is exactly what happened to Thomas Kornberg, a professor with Hodgkin’s Lymphoma who was forced to contact doctor-friends to supply his need.

The American Hospital Association just issued a press release showing the results of their recent survey that exposed this apparent drug shortage:

  • Hospitals report that they have delayed treatment (82%) and more than half were not always able to provide the patient with the recommended treatment
  • Patients got a less effective drug (69%)
  • Hospitals experienced drug shortages across all treatment categories
  • Most hospitals rarely or never receive advance notification of drug shortages (77%) or are informed about the cause of the shortage (67%)
  • The vast majority of all hospitals reported increased drug costs as a result of drug shortages
    • Most hospitals are purchasing more expensive alternative drugs from other sources

The AHA has proposed some solutions: They want to establish early warning systems of shortages, remove regulatory obstacles, improve communication among stakeholders, and explore incentives to encourage drug manufacturers to stay in, re-enter or initially enter the market.

Clearly Kornberg is not the only case,

So what happened to the other people who don’t have the connections/resources that he does?

How are hospitals to deliberate on the dispersion of scarce resources?

Even more concerning, if this becomes a trend, will there be an even larger motive for inconspicuous sales?

 

1
Leave a Reply

Please Login to comment
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
1 Comment authors
Jon Holmlund, M.D. Recent comment authors
  Subscribe  
newest oldest most voted
Notify of
Jon Holmlund, M.D.
Guest
Jon Holmlund, M.D.

Drug shortages remain a thorny problem that are again in the news. Most of the medically-critical ones involve older drugs, sterile, for injection. Many are indeed irreplaceable, hard to make, and so cheap that there is often a financial disincentive to drug companies to make them. A troubling response is the (illegal) sale of expensive, “grey market” knockoffs. Notification–currently voluntary to the FDA except when a company intends to stop making a critically needed drug altogether–is one part of the solution, and new legislation has been proposed to that end. But other issues include raw materials supply, manufacturing hiccups/delays, and… Read more »